niacinamide has been researched along with Hyponatremia in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Hyponatremia is reported to be associated with poor survival in localized renal cell carcinoma and metastatic renal cell carcinoma treated with immunotherapy." | 1.38 | Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy. ( Arai, Y; Kawashima, A; Nakai, Y; Nin, M; Nishimura, K; Nonomura, N; Takayama, H; Tanigawa, G; Tsujimura, A; Uemura, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furukawa, J | 1 |
Miyake, H | 1 |
Kusuda, Y | 1 |
Fujisawa, M | 1 |
Kawashima, A | 1 |
Tsujimura, A | 1 |
Takayama, H | 1 |
Arai, Y | 1 |
Nin, M | 1 |
Tanigawa, G | 1 |
Uemura, M | 1 |
Nakai, Y | 1 |
Nishimura, K | 1 |
Nonomura, N | 1 |
Saito, K | 1 |
Vázquez-Alonso, F | 1 |
Puche-Sanz, I | 1 |
4 other studies available for niacinamide and Hyponatremia
Article | Year |
---|---|
Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor.
Topics: Aged; Antineoplastic Agents; C-Reactive Protein; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Dise | 2015 |
Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; C-Reactive Protein; Carcinoma | 2012 |
Editorial comment from Dr Saito to impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Female; Humans; Hyponatremia; Indoles; Kidney Neoplasms; Male | 2012 |
Editorial comment from Dr Vázquez-Alonso and Dr Puche-Sanz to impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy.
Topics: Bone Neoplasms; Carcinoma, Renal Cell; Female; Humans; Hyponatremia; Indoles; Kidney Neoplasms; Male | 2012 |